These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16125032)

  • 1. Subcutaneous administration of cefepime.
    Walker P; Neuhauser MN; Tam VH; Willey JS; Palmer JL; Bruera E; Prince RA
    J Pain Symptom Manage; 2005 Aug; 30(2):170-4. PubMed ID: 16125032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of cefepime (BMY-28142), a broad-spectrum cephalosporin, in dogs.
    Stampley AR; Brown MP; Gronwall RR; Castro L; Stone HW
    Cornell Vet; 1992 Jan; 82(1):69-77. PubMed ID: 1740062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies.
    Lodise TP; Rhoney DH; Tam VH; McKinnon PS; Drusano GL
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):223-30. PubMed ID: 16423490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular penetration of cefepime following systemic administration in humans.
    Ozdamar A; Aras C; Ozturk R; Karacorlu M; Bahcecioglu H; Ozkan S
    Ophthalmic Surg Lasers; 2001; 32(1):25-9. PubMed ID: 11195739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
    Lima-Rogel V; Medina-Rojas EL; Del Carmen Milán-Segovia R; Noyola DE; Nieto-Aguirre K; López-Delarosa A; Romano-Moreno S
    J Clin Pharm Ther; 2008 Jun; 33(3):295-306. PubMed ID: 18452417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
    Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC; Wagner DJ
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-proportional pharmacokinetics of cefepime in rats.
    Brindley CJ; Brodie RR; Cook SC; Oldfield PR; Chasseaud LF; Barbhaiya RH
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():9-14. PubMed ID: 1820942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime pharmacokinetics in cystic fibrosis.
    Hamelin BA; Moore N; Knupp CA; Ruel M; Vallée F; LeBel M
    Pharmacotherapy; 1993; 13(5):465-70. PubMed ID: 8247913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
    Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of parenteral dexketoprofen trometamol in healthy subjects.
    Valles J; Artigas R; Crea A; Muller F; Paredes I; Zapata A; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():7-12. PubMed ID: 16801987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA; Eubanks DA; Adelman MH; Schentag JJ
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.